CN Stock MarketDetailed Quotes

Hangzhou Biotest Biotech (688767)

Watchlist
  • 42.13
  • -1.05-2.43%
Market Closed Jan 16 15:00 CST
6.29BMarket Cap61.32P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hangzhou Biotest Biotech (688767) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
POCT产品业务及其他203.28M100.00%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
In vitro diagnosis industry519.74M92.91%
Other business39.67M7.09%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Overseas147.64M72.63%
Territory55.64M27.37%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +7.11%
Sample Name
Sample Code
 +3.77%
Sample Name
Sample Code
 +2.24%
4
Broadcom
AVGO
+1.15%
5
Microsoft
MSFT
+1.05%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -